Avastin (bevacizumab) - Important Safety Information from Roche as approved by the Irish Medicines Board

Notice type: 3rd Party Publications

Date: 08/12/2010


Problem Or Issue:

Important safety information communication from Roche on Osteonecrosis of the jaw in cancer patients in association with bevacizumab, Avastin® and concomitant or previous use of biphosphonates.

Important Safety Information - Avastin (bevacizumab)


« Back